In Depth

Readmission on the Horizon: How EU funding can boost British biotech

NASH drugs race to cross the finish line

Can vouchers incentivise antimicrobial drug discovery in Europe?

Q&A: How Big Pharma implements analytics in continuous manufacturing

Inflation reduction act boosts biologic VC financing over small molecules